Sort by
Refine Your Search
-
models. Current treatment strategies for HBV are life-long and rarely curative. Finite antiviral and immunomodulatory therapeutic strategies are being pursued for an HBV functional cure to treat the 254
-
responses induced in antigen presenting cells, and the differentiation of specific B and T cells will be evaluated by spectral flow cytometry and scRNAseq, while CD4+ T cell / B cell interactions will be
-
models, flow cytometry, confocal microscopy and unbiased approaches such as single cells transcriptomics, spatial transcriptomics and epigenetics to characterize molecular and cellular mechanisms. Using
-
perturbations), pharmacological interventions (senolytics and senomorphics), and organoid systems with functional assays, flow cytometry, advanced imaging, and high-dimensional approaches, including single-cell